- D20A0002 The Stem Cell Sheet for Neurovascular Reconstruction
- D20A0001 The Development of Humanized Monoclonal Antibody Therapy Targeting Dengue Virus NS1
- D20A0006 Adenosine Augmentation, A Novel Therapeutic Strategy for Neurodegenerative Diseases
- D20A0005 Vaccine Antigens against Acinetobacter Baumannii
- D20A0004 Development of Novel Polysaccharide Nanoparticles as Vaccine Nano-carrier and Adjuvant
- D20A0003 Bloodless AI-assisted ECG System to Rapidly Detect Life-threatening Dyskalemia
- D19A0025 Development of Anti-Lung Cancer Peptide Drug
- D19A0024 Customizable Particles to Enhance the Immunogenicity of Peptide-based T Cell Vaccines
- D19A0023 Development of Antibody Drug AP001 against a Novel Tumor Marker Protein AP for Human Cancer Treatment
- D19A0022 A New Combinational Treatment Method of TMG/DMG with Ketamine for Psychiatric Disorders
DCC
Banner
